Attitudes of Patients about Personalized Medicine | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Understanding the Role of Personalized Medicine

recurrence risk for breast cancer »

Attitudes of Patients about Personalized Medicine

March 2, 2013 by larryhbern

Attitudes of Patients about Personalized Medicine

Curator: Larry H Bernstein, MD, FCAP

Attitudes of Patients With Cancer About Personalized Medicine

SW Gray, K Hicks-Courant, et al.

jop.ascopubs.org/content/8/6/329.full.pdf

http://ovariancancerandus.blogspot.com/…/jop-attitudes-of-patients-With-Cancer-About-Personalized-Medicine-and-Somatic-Genetic-Testing/

Personalized Medicine

Personalized Medicine (Photo credit: Wikipedia)

Related articles

Personalized medicine gearing up to tackle cancer (pharmaceuticalintelligence.com)
https://pharmaceuticalintelligence.wordpress.com/wp-admin/Understanding_the_Role_of_Personalized_Medicine
Nanotechnology, personalized medicine and DNA sequencing (pharmaceuticalintelligence.com)
Institute for Personalized Medicine established by UPMC (triblive.com)
Personalized medicine: the future of medicine! (gtms1314.wordpress.com)
https://pharmaceuticalintelligence.com/2013/01/13/paradigm-shift-in-human-genomics-predictive-biomarkers-and-personalized-medicine-part-1/
https://pharmaceuticalintelligence.com/2013/02/27/genomics-ethics-dna-fragments-are-products-of-nature-or-patentable-genes/

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Genome Biology, Genomic Testing: Methodology for Diagnosis, Health Economics and Outcomes Research, Health Law & Patient Safety, International Global Work in Pharmaceutical, Molecular Genetics & Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Population Health Management, Genetics & Pharmaceutical, Technology Transfer: Biotech and Pharmaceutical | Tagged Biology, Cancer - General, Conditions and Diseases, health, Larry H. Bernstein, medicine, Ohio State University Medical Center, ovarian cancer, Personalized medicine | 5 Comments

5 Responses

on March 3, 2013 at 9:21 PM | Reply The Promise of Personalized Medicine | Pharmaceutical Intelligence

[…] Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com) […]
on March 27, 2013 at 5:45 PM | Reply Ethical Concerns in Personalized Medicine: BRCA1/2 Testing in Minors and Communication of Breast Cancer Risk | Pharmaceutical Intelligence

[…] Attitudes of Patients about Personalized Medicine […]
on March 27, 2013 at 7:00 PM | Reply Genomic Liberty of Ownership, Genome Medicine and Patenting the Human Genome | Pharmaceutical Intelligence

[…] 20.3 Attitudes of Patients about Personalized Medicine […]
on April 3, 2013 at 9:21 AM | Reply Paralysis by Sequestration and the Medical Revolution | Pharmaceutical Intelligence

[…] Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com) […]
on July 24, 2014 at 12:33 PM | Reply Series B: Frontiers in Genomics Research | Scientific Curation Services

[…] 20.3 Attitudes of Patients about Personalized Medicine […]

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: